ANIXA BIOSCIENCES, INC. Payments to Suppliers and Employees
ANIXA BIOSCIENCES, INC. (ANIX) reported Payments to Suppliers and Employees of $3.40 million for the 12-month period ending 2013-10-31, per its 10-K/A filed 2014-01-17.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:PaymentsToSuppliersAndEmployees · last filed 2014-01-17
- ANIXA BIOSCIENCES, INC. payments to suppliers and employees for the quarter ending 2013-10-31 was $756.10K, a 21.62% decline year-over-year.
- ANIXA BIOSCIENCES, INC. payments to suppliers and employees for the quarter ending 2013-07-31 was $4.45M, a 18.58% increase year-over-year.
- ANIXA BIOSCIENCES, INC. payments to suppliers and employees for the quarter ending 2013-04-30 was -$912.76K.
- ANIXA BIOSCIENCES, INC. payments to suppliers and employees for the quarter ending 2013-01-31 was -$892.90K.
- ANIXA BIOSCIENCES, INC. payments to suppliers and employees for fiscal 2013 was $3.40M, a 7.49% increase from fiscal 2012.
- ANIXA BIOSCIENCES, INC. payments to suppliers and employees for fiscal 2012 was $3.16M.
- ANIXA BIOSCIENCES, INC. payments to suppliers and employees for fiscal 2011 was -$3.28M, a 202.19% decline from fiscal 2010.
- ANIXA BIOSCIENCES, INC. payments to suppliers and employees for fiscal 2010 was $3.21M.
| Period end | Payments to Suppliers and Employees 3 month | Payments to Suppliers and Employees 3 month as first filed | Payments to Suppliers and Employees 6 month | Payments to Suppliers and Employees 6 month as first filed | Payments to Suppliers and Employees 9 month | Payments to Suppliers and Employees 9 month as first filed | Payments to Suppliers and Employees 12 month | Payments to Suppliers and Employees 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2013-10-31 | $756.10K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2014-01-17 | $5.21M derived: sum of 2 quarters · filed 2014-01-17 | $4.29M derived: sum of 3 quarters · filed 2014-01-17 | $3.40M 10-K/A · filed 2014-01-17 | ||||
| 2013-07-31 | $4.45M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2013-09-20 | $3.54M derived: sum of 2 quarters · filed 2013-09-20 | $2.65M 10-Q/A · filed 2013-09-20 | $3.61M derived: sum of 4 quarters · filed 2014-01-17 | ||||
| 2013-04-30 | -$912.76K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2013-06-19 | -$1.81M 10-Q/A · filed 2013-06-19 | -$840.96K derived: sum of 3 quarters · filed 2014-01-17 | $2.91M derived: sum of 4 quarters · filed 2014-01-17 | ||||
| 2013-01-31 | -$892.90K 10-Q/A · filed 2013-03-25 | $71.80K derived: sum of 2 quarters · filed 2014-01-17 | $3.83M derived: sum of 3 quarters · filed 2014-01-17 | $2.93M derived: sum of 4 quarters · filed 2014-01-17 | ||||
| 2012-10-31 | $964.70K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2014-01-17 | $4.72M derived: sum of 2 quarters · filed 2014-01-17 | $3.82M derived: sum of 3 quarters · filed 2014-01-17 | $3.16M 10-K/A · filed 2014-01-17 | -$3.16M 10-K · filed 2013-01-29 | |||
| 2012-07-31 | $3.75M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2013-09-20 | $2.86M derived: sum of 2 quarters · filed 2013-09-20 | $2.20M 10-Q/A · filed 2013-09-20 | -$2.20M 10-Q · filed 2012-09-14 | $1.49M derived: sum of 4 quarters · filed 2013-09-20 | |||
| 2012-04-30 | -$894.01K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2013-06-19 | -$1.55M 10-Q/A · filed 2013-06-19 | $1.55M 10-Q · filed 2012-06-14 | -$2.27M derived: sum of 3 quarters · filed 2013-06-19 | -$6.27M derived: sum of 4 quarters · filed 2013-06-19 | |||
| 2012-01-31 | -$659.78K 10-Q/A · filed 2013-03-25 | $659.78K 10-Q · filed 2012-03-16 | -$1.37M derived: sum of 2 quarters · filed 2013-03-25 | -$5.38M derived: sum of 3 quarters · filed 2013-03-25 | -$4.56M derived: sum of 4 quarters · filed 2013-03-25 | |||
| 2011-10-31 | -$713.05K derived: 10-K 12 month − 10-Q 9 month · filed 2013-01-29 | -$4.72M derived: sum of 2 quarters · filed 2013-01-29 | -$3.90M derived: sum of 3 quarters · filed 2013-01-29 | -$3.28M 10-K · filed 2013-01-29 | $3.28M 10-K · filed 2012-01-30 | |||
| 2011-07-31 | -$4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-09-14 | -$3.19M derived: sum of 2 quarters · filed 2012-09-14 | -$2.57M 10-Q · filed 2012-09-14 | $2.57M 10-Q/A · filed 2011-10-14 | -$1.73M derived: sum of 4 quarters · filed 2012-09-14 | |||
| 2011-04-30 | $814.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-06-14 | $1.44M 10-Q · filed 2012-06-14 | $2.28M derived: sum of 3 quarters · filed 2012-06-14 | |||||
| 2011-01-31 | $623.51K 10-Q · filed 2012-03-16 | $1.46M derived: sum of 2 quarters · filed 2012-03-16 | ||||||
| 2010-10-31 | $837.32K derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-01-30 | $3.21M 10-K · filed 2012-01-30 | ||||||
| 2010-07-31 | $2.37M 10-Q/A · filed 2011-10-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |